Webcast: Partnering with Patients to Access Medicines

This is a live non-CE event. We thank our sponsors Amgen, Inc and Bristol-Meyers Squibb/Pfizer, Inc. for making this program possible.

May 24, 2018
10:00 AM Pacific, 11:00 AM Mountain, 12:00 PM Central, 1:00 PM Eastern

This non-CE live webcast is one of the final installments in PCNA’s year-long campaign to raise awareness about the barriers and challenges related to patient access to new and innovative cardiovascular medicines including: 1) the PCSK9 class for LDL-cholesterol lowering, 2) the ARNI class indicated for the management of heart failure, and 3) the novel oral anticoagulants for the prevention of stroke in atrial fibrillation. We have collected best practices and practical resources to share throughout the year and will be highlighted throughout this program.
0.00